LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT)

CUSIP: 539319301

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
2,666,933
Total 13F shares
300,011
Share change
+2,454
Total reported value
$384,657
Price per share
$1.21
Number of holders
9
Value change
-$81,359
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 539319301?
CUSIP 539319301 identifies LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) as of Q1 2025

As of 31 Mar 2025, LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 300,011 shares. The largest 9 holders included FNY Investment Advisers, LLC, HighTower Advisors, LLC, Ethos Financial Group, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Atlas Legacy Advisors, LLC, UBS Group AG, SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.